Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 6/2005

01-06-2005 | Guest Editorial

IOP and the risk of progression to glaucoma

Author: Robert N. Weinreb

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 6/2005

Login to get access

Excerpt

Only some individuals with ocular hypertension ultimately will develop the visual field abnormalities or optic neuropathy characteristic of primary open-angle glaucoma. In daily clinical practice, physicians often need to determine whether an individual patient with ocular hypertension should be treated or monitored at regular intervals to detect progression. An enhanced understanding of risk factors that contribute to the progression of ocular hypertension can aid in therapeutic decision-making. …
Literature
1.
Asrani S, Zeimer R, Wilensky J, Geiser D, Vitale S, Lindenmuth K (2000) Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 9:134–142PubMed
2.
Bengttson B, Heijl A (2005) Diurnal IOP fluctuation:not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefe Arch Clin Exp Ophthalmol DOI 10.​1007/​s00-117-004-1103-8
3.
Bergea B, Bodin L, Svedbergh B (1999) Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology 106:997–1005CrossRefPubMed
4.
Kass MS, Heuer DK, Higginbotham EJ, Ocular Hypertension Treatment Study Group (2002) The ocular treatment study. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713PubMed
5.
Liu JHK, Zhang X, Kripke DF, Weinreb RN (2003) Nocturnal elevation of intraocular pressure is detectable in the sitting position. Invest Ophthalmol Vis Sci 44:4439–4442CrossRefPubMed
6.
Mosaed S, Liu JHK, Weinreb RN (2005) Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients. Am J Ophthalmol 139:320–324CrossRefPubMed
7.
Weinreb RN, Friedman DS, Fechtner RD et al (2004) Risk assessment in the management of patients with ocular hypertension. Am J Ophthalmol 138:458–467CrossRefPubMed
Metadata
Title
IOP and the risk of progression to glaucoma
Author
Robert N. Weinreb
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 6/2005
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-005-1195-9

Other articles of this Issue 6/2005

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2005 Go to the issue

Case Report

Macular translocation with 360° retinotomy for retinal pigment epithelial tear

Case Report

Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy

Clinical Investigation

Surgical excision of neovascularization in retinal angiomatous proliferation

Case Report

Primary basal cell carcinoma of the caruncle with seeding to the conjunctiva

Clinical Investigation

Indocyanine green angiography and fluorescein angiography of malignant choroidal melanomas following proton beam irradiation

Clinical Investigation

Traumatic globe rupture following penetrating keratoplasty